Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Receivables - Other: 2021-2022

Historic Receivables - Other for ADC Therapeutics (ADCT) over the last 1 years, with Dec 2022 value amounting to $805,000.

  • ADC Therapeutics' Receivables - Other rose 2.03% to $805,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $805,000, marking a year-over-year increase of 2.03%. This contributed to the annual value of $805,000 for FY2022, which is 2.03% up from last year.
  • Per ADC Therapeutics' latest filing, its Receivables - Other stood at $805,000 for Q4 2022, which was down 52.51% from $1.7 million recorded in Q3 2022.
  • In the past 5 years, ADC Therapeutics' Receivables - Other registered a high of $1.7 million during Q3 2022, and its lowest value of $789,000 during Q4 2021.
  • Moreover, its 2-year median value for Receivables - Other was $876,000 (2022), whereas its average is $1.0 million.
  • Data for ADC Therapeutics' Receivables - Other shows a peak YoY increased of 2.03% (in 2022) over the last 5 years.
  • Over the past 2 years, ADC Therapeutics' Receivables - Other (Quarterly) stood at $789,000 in 2021, then climbed by 2.03% to $805,000 in 2022.
  • Its Receivables - Other was $805,000 in Q4 2022, compared to $1.7 million in Q3 2022 and $876,000 in Q2 2022.